[Ip-health] NYT: Chinese Ebola drug raises hopes, and rancor

Suerie Moon suerie_moon at yahoo.com
Fri Jun 12 12:08:35 PDT 2015

Hi all, interesting piece in the NYT about a Chinese drug that is similar to ZMapp and has raised some IP-related concerns at BARDA. Also interesting to note that the original title of this article was "Chinese Ebola drug brings American objections," and has since been changed to "Chinese Ebola drug raises hopes, and rancor".-Suerie
A Chinese Ebola Drug Raises Hopes, and Rancor

|   |
|   |  |   |   |   |   |   |
| A Chinese Ebola Drug Raises Hopes, and RancorThe production of an experimental Ebola treatment by a small Chinese company has led to patent infringement claims by American officials and disagreements among... |
|  |
| View on www.nytimes.com | Preview by Yahoo |
|  |
|   |

Suerie Moon, MPA, PhD
Research Director and Co-Chair, Forum on Global Governance for Health, Harvard Global Health Institute 
Study Director, Harvard-LSHTM Independent Panel on the Global Response to Ebola
Lecturer, Department of Global Health and Population, Harvard School of Public Health
Project Co-Director, Innovation and Access to Technologies for Sustainable Development, Sustainability Science Program, Harvard Kennedy School of Government
104 Mount Auburn Street, 3rd Floor, Cambridge, MA 02138, USA
smoon at hsph.harvard.edu

More information about the Ip-health mailing list